In a recent blog post (http://evmed.asu.edu/blog/evolutionary-medicine-top-ten-questions), Randy Nesse suggests that the presentations and discussions at the second annual conference of the International Society for Evolution, Medicine, and Public Health (ISEMPH) were...
Mel Greaves, The Institute of Cancer Research July 20, 2015, doi: 10.1158/2159-8290.CD-15-0439 Full Text PDF Abstract Our understanding of cancer is being transformed by exploring clonal diversity, drug resistance, and causation within an evolutionary framework. The...
Andrii I. Rozhok and James DeGregori July 21, 2015, doi:10.1073/pnas.1501713112 Full Text PDF PNAS July 21, 2015 vol. 112 no. 298914-8921 Abstract Our understanding of cancer has greatly advanced since Nordling [Nordling CO (1953) Br J Cancer7(1):68–72] and Armitage...
It would be hard to identify an approach to cancer treatment that has received more attention recently than anti-checkpoint therapy (Pollack, 2015). This strategy for eliminating tumor cells is based on interfering with one or another pathway that inhibits the...
Carcinomas of the prostate are the most common cancers affecting men and a leading cause of male cancer deaths in the United States (CDC web site, Cancer Prevention and Control). Given the unique association of the prostate with males, it makes sense that prosate...
